Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tan To Cheung

Showing results (221-230 of 298) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|December 25, 2019
Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis BJames Fung, Lung-Yi Mak, Albert Chi-Yan Chan, et al.
Liver Cancer|April 18, 2018
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular CarcinomaTom Tan-To Cheung, Philip Chong-Hei Kwok, Stephen Chan, et al.
Journal of Hepatology|March 1, 2022
Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinomaAbdullah Husain, Yung-Tuen Chiu, Karen Man-Fong Sze, et al.
Cancer Letters|May 18, 2019
The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinomaSze Wai Fung, Phyllis Fung-Yi Cheung, Chi Wai Yip, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 22, 2023
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerCharles Shing Kam, Daniel Wai-Hung Ho, Vanessa Sheung-In Ming, et al.
Liver Cancer|September 26, 2022
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and TaiwanThomas Yau, David Tai, Stephen Lam Chan, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2024
Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC CellsYu-Man Tsui, Daniel Wai-Hung Ho, Karen Man-Fong Sze, et al.
World Journal of Gastroenterology|May 30, 2013
High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patientsTan To Cheung, Sheung Tat Fan, See Ching Chan, et al.
Alimentary Pharmacology & Therapeutics|March 17, 2025
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular CarcinomaSubin Heo, Jiwon Yang, Jeayeon Park, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
Pageof 30

Showing results (221-230 of 298) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|December 25, 2019
Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis BJames Fung, Lung-Yi Mak, Albert Chi-Yan Chan, et al.
Liver Cancer|April 18, 2018
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular CarcinomaTom Tan-To Cheung, Philip Chong-Hei Kwok, Stephen Chan, et al.
Journal of Hepatology|March 1, 2022
Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinomaAbdullah Husain, Yung-Tuen Chiu, Karen Man-Fong Sze, et al.
Cancer Letters|May 18, 2019
The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinomaSze Wai Fung, Phyllis Fung-Yi Cheung, Chi Wai Yip, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 22, 2023
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerCharles Shing Kam, Daniel Wai-Hung Ho, Vanessa Sheung-In Ming, et al.
Liver Cancer|September 26, 2022
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and TaiwanThomas Yau, David Tai, Stephen Lam Chan, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2024
Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC CellsYu-Man Tsui, Daniel Wai-Hung Ho, Karen Man-Fong Sze, et al.
World Journal of Gastroenterology|May 30, 2013
High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patientsTan To Cheung, Sheung Tat Fan, See Ching Chan, et al.
Alimentary Pharmacology & Therapeutics|March 17, 2025
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular CarcinomaSubin Heo, Jiwon Yang, Jeayeon Park, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Dual-tracer PET/CT in the management of hepatocellular carcinomaKeith Wan Hang Chiu, Chi Leung Chiang, Kenneth Sik Kwan Chan, et al.
Pageof 30